Search for: "Merck & Co, Inc. v. United States" Results 81 - 100 of 168
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Feb 2016, 1:32 pm by Lawrence B. Ebert
United States, 522 F.3d 937, 940 (9th Cir. 2008); see United States v. [read post]
5 Jul 2007, 10:37 am
United States, 740 F.2d 1428, 1440 (8th Cir. 1984); Madsen v. [read post]
19 Jun 2011, 10:13 pm
United States, 434 F.3d 1359, 1368 (Fed. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
13 Aug 2015, 10:56 am
  This principle could certainly apply to innovator manufacturers as well in circumstances where the manufacturer could not make the proposed changes without government assistance.Mutual Pharmaceutical Co., Inc. v. [read post]
30 Aug 2019, 6:31 am
Interestingly, Canadian courts used to follow the British approach but, in its recent decision in Merck & Co. v. [read post]
2 Sep 2009, 11:22 pm
Merck & Co., 949 A.2d 223, 271-76 (N.J. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
(Appeal from MD State Court) Anticipation/Obviousness: Google Inc., et al. v. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years… [read post]
6 Jul 2007, 4:29 am
Upjohn Co., 778 A.2d 829, 836-38 (Conn. 2001); Coyle v. [read post]
22 Feb 2008, 1:30 pm
The administration is supporting the manufacturer in that case, Warner-Lambert Co. v. [read post]
24 May 2007, 10:40 am
Upjohn Co., 778 A.2d 829, 846 (Conn. 2001); Niemiera v. [read post]